The Placebo composition is the same of the IMP except the active ingredient
CHF6467-OPG
Phase 2 small_molecule active
Quick answer
The Placebo composition is the same of the IMP except the active ingredient for Optic Pathway Glioma (OPG) is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Optic Pathway Glioma (OPG)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active